CC•benzinga•
Chemours Q4 Earnings: Mixed Results, Moderate Outlook, 'Pathway To Thrive' In Action & More
Summary
Chemours Company reports Q4 net sales of $1.359 billion, in line with consensus. Adjusted EBITDA improved 2% Y/Y. FY25 outlook positive.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 18, 2025 by benzinga